was born on July 12th, 1935

Full Name: Satoshi ?mura
Profession: Biochemist and Academic
Nationality: Japanese
Born: 1935
Notable Achievement: Nobel Prize in Physiology or Medicine
Known For: Discovery of protein kinase
Alma Mater: University of Tokyo
Awards: Japan Academy Prize

A Japanese biochemist and academic who discovered the avermectin family of compounds, leading to the development of ivermectin, a drug used to treat parasitic diseases.

Written by: Lisa Chang Lisa Chang

Satoshi Ōmura: The Nobel Laureate Revolutionizing Medicine with Microorganisms

The Discovery of Avermectins and Ivermectin

Satoshi Ōmura, a Japanese biochemist, is renowned for his groundbreaking discovery and development of hundreds of pharmaceuticals derived from microorganisms. In 2015, he was awarded the Nobel Prize in Physiology or Medicine, alongside William C. Campbell and Tu Youyou, for his pioneering work on avermectins and ivermectin, the world's first endectocide and a safe, highly effective microfilaricide.

Early Life and Education

Born on July 12, 1935, in Nirasaki, Yamanashi, Japan, Satoshi Ōmura was the second son of the Ōmura family. He pursued his undergraduate degree at the University of Yamanashi, graduating in 1958. Initially, he worked as a science teacher at Tokyo Metropolitan Sumida Tech High School, before becoming an auditor of Koji Nakanishi's course at Tokyo University of Education in 1960. A year later, he enrolled in the Tokyo University of Science, where he studied sciences and earned his M.S. degree. Ōmura furthered his education, receiving his Ph.D. in Pharmaceutical Sciences from the University of Tokyo in 1968, and a Ph.D. in Chemistry from Tokyo University of Science in 1970.

Career and Research Contributions

Satoshi Ōmura's illustrious career began in 1965, when he joined the Kitasato Institute system. During the 1970s, he worked as a part-time lecturer at Tokyo University of Science, in addition to his role at Kitasato University. In 1971, as a visiting professor at Wesleyan University, he collaborated with Max Tishler, chairman of the American Chemical Society, to secure research funding from Merck & Co. This partnership marked the beginning of a fruitful collaboration between Ōmura and Merck & Co., which would last for several decades.

The Breakthrough Discovery

In 1975, Ōmura became the director of the antibiotic laboratory at Kitasato University, where he began his groundbreaking research on microorganisms. His team's discovery of avermectins, a new class of antibiotics, led to the development of ivermectin, a drug that has revolutionized the treatment of parasitic diseases, including river blindness. Ivermectin's large molecular size prevents it from crossing the blood-aqueous humor barrier, making it an essential treatment for helminthically-derived blindness.

Awards and Honors

Legacy and Impact

Satoshi Ōmura's pioneering work has had a profound impact on modern medicine, enabling the development of life-saving treatments for millions of people worldwide. His discovery of avermectins and ivermectin has opened up new avenues for research into microorganisms, unlocking the secrets of these tiny organisms and their potential to improve human health. As a renowned scientist and Nobel laureate, Ōmura continues to inspire future generations of researchers, fostering a spirit of innovation and collaboration in the pursuit of medical breakthroughs.

Timeline
1934
Born in Japan
Satoshimura was born on November 25, 1934, in Japan. He grew up with an interest in biochemistry and medicine.
1962
Earned Ph.D. from University of Tokyo
Satoshimura earned his Ph.D. in biochemistry from the University of Tokyo.
1981
Made groundbreaking discovery
Satoshimura made a groundbreaking discovery in the field of biochemistry, which led to significant advances in the understanding of cellular processes.
1994
Won Nobel Prize in Physiology or Medicine
Satoshimura was awarded the Nobel Prize in Physiology or Medicine for his discovery of the G-protein coupled receptors.
2016
Passed away at 82
Satoshimura passed away on June 16, 2016, at the age of 82, leaving behind a legacy as a pioneering biochemist and Nobel laureate.
Satoshi ?mura

Quiz

Satoshi ?mura is a renowned biochemist from which country?

Score: 0/5
FAQ
What is Satoshi Ōmuras most significant scientific contribution?
Satoshi Ōmura is a Nobel laureate who, along with William Campbell and Youyou Tu, discovered the avermectins, a class of compounds used to treat parasitic diseases.
How did Satoshi Ōmuras research on microorganisms impact the development of new medicines?
Ōmuras research on microorganisms led to the discovery of novel compounds with antibiotic, antifungal, and antiparasitic properties, expanding the range of treatments for various diseases.
What is Satoshi Ōmuras approach to scientific research?
Ōmura is known for his meticulous and thorough approach to scientific research, emphasizing the importance of basic research and serendipity in discovery.
Did Satoshi Ōmura hold any leadership positions in scientific organizations?
Yes, Ōmura served as the president of the Kitasato Institute and the Japan Antibiotics Research Association, promoting scientific collaboration and advancement.
How did Satoshi Ōmuras work impact global health?
Ōmuras discovery of the avermectins has saved millions of lives worldwide, particularly in developing countries, by providing effective treatment for diseases such as river blindness and elephantiasis.

Related People:

Leo Esaki

Born in 1925

A Japanese physicist and academic who discovered the phenomenon of electron tunneling, earning him a Nobel Prize in Physics in 1973. His work led to the development of semiconductors and modern electronics.

Hideki Yukawa

Born in 1907

Predicted the existence of mesons, subatomic particles that mediate the strong nuclear force, and was the first Japanese person to receive a Nobel Prize in Physics.

Ryōji Noyori

87 Years Old

A Japanese chemist and Nobel laureate who developed innovative methods for synthesizing organic compounds, particularly chirally active molecules, revolutionizing pharmaceutical and agrochemical industries.